Corriente Advisors

Latest statistics and disclosures from Corriente Advisors's latest quarterly 13F-HR filing:

Portfolio Holdings for Corriente Advisors

Companies in the Corriente Advisors portfolio as of the June 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Maxar Technologies (MAXR) 22.1 $34M +12% 1.9M 17.96
Reata Pharmaceuticals Cl A (RETA) 14.9 $23M -22% 148k 156.02
Sonos (SONO) 14.9 $23M NEW 1.6M 14.63
Aptose Biosciences Com New (APTO) 11.3 $18M -5% 2.8M 6.31
Cue Biopharma (CUE) 10.5 $16M -19% 660k 24.51
Replimune Group (REPL) 7.8 $12M NEW 485k 24.85
Uniqure Nv SHS (QURE) 5.3 $8.1M NEW 180k 45.06
Ocular Therapeutix (OCUL) 3.9 $6.0M NEW 720k 8.33
Celldex Therapeutics Com New (CLDX) 3.9 $6.0M NEW 460k 13.00
Tesla Motors (TSLA) 1.4 $2.2M 2.0k 1080.00
Arrowhead Pharmaceuticals (ARWR) 1.1 $1.7M NEW 40k 43.20
Diamedica Therapeutics Com New (DMAC) 0.9 $1.4M NEW 201k 6.93
Pan American Silver Corp Can (PAAS) 0.6 $912k NEW 30k 30.40
Cardiff Oncology 0.6 $869k NEW 173k 5.01

Setup an alert

Corriente Advisors will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Pieris Pharmaceuticals (PIRS) 0.5 $837k -84% 270k 3.10
Redwood Trust (RWT) 0.3 $525k NEW 75k 7.00

Past Filings by Corriente Advisors

SEC 13F filings are viewable for Corriente Advisors going back to 2010